|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.25 GBX | +1.38% |
|
+13.28% | -1.85% |
| 07-17 | FTSE 100 bucks European AI stock selloff | AN |
| 07-17 | WINNERS & LOSERS: Vega ups Vodafone stake; GSK drug trial disappoints | AN |
| Fiscal Period: June | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.07 | 6.73 | 6.22 | 2.27 | 1.58 | |||||
Return on Total Capital | 5.44 | 12.95 | 13.37 | 4.99 | 3.5 | |||||
Return On Equity % | 7.13 | 18.49 | 18.86 | -0.8 | -1.52 | |||||
Return on Common Equity | 7.13 | 18.49 | 18.86 | -0.8 | -1.52 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 5.17 | 6.4 | 5.63 | 4.21 | 4.06 | |||||
SG&A Margin | 2.28 | 2.16 | 2.1 | 2.28 | 2.42 | |||||
EBITDA Margin % | 2.07 | 3.53 | 2.89 | 1.25 | 0.96 | |||||
EBITA Margin % | 1.86 | 3.38 | 2.74 | 1.09 | 0.8 | |||||
EBIT Margin % | 1.66 | 3.23 | 2.61 | 0.96 | 0.69 | |||||
Income From Continuing Operations Margin % | 1.09 | 2.34 | 1.82 | -0.07 | -0.12 | |||||
Net Income Margin % | 1.09 | 2.34 | 1.82 | -0.07 | -0.12 | |||||
Net Avail. For Common Margin % | 1.09 | 2.34 | 1.82 | -0.07 | -0.12 | |||||
Normalized Net Income Margin | 0.97 | 1.98 | 1.58 | 0.52 | 0.32 | |||||
Levered Free Cash Flow Margin | 0.13 | 2.95 | 0.9 | 1.15 | 2.11 | |||||
Unlevered Free Cash Flow Margin | 0.2 | 3 | 0.97 | 1.26 | 2.24 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 2.96 | 3.34 | 3.81 | 3.77 | 3.68 | |||||
Fixed Assets Turnover | 24.26 | 31.47 | 37.28 | 35.35 | 35.18 | |||||
Receivables Turnover (Average Receivables) | 10.95 | 11.23 | 10.91 | 9.38 | 9.31 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.63 | 1.35 | 1.32 | 1.32 | 1.25 | |||||
Quick Ratio | 1.58 | 1.31 | 1.28 | 1.27 | 1.19 | |||||
Operating Cash Flow to Current Liabilities | 0.01 | 0.15 | 0.16 | 0.1 | 0.1 | |||||
Days Sales Outstanding (Average Receivables) | 33.32 | 32.5 | 33.46 | 39.01 | 39.2 | |||||
Average Days Payable Outstanding | 11.28 | 12.74 | 14.23 | 16.48 | 18.13 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 23.07 | 23.25 | 29.81 | 43.81 | 66.9 | |||||
Total Debt / Total Capital | 18.74 | 18.86 | 22.96 | 30.47 | 40.08 | |||||
LT Debt/Equity | 18.83 | 18.25 | 23.65 | 35.89 | 50.55 | |||||
Long-Term Debt / Total Capital | 15.3 | 14.81 | 18.22 | 24.95 | 30.29 | |||||
Total Liabilities / Total Assets | 53.47 | 61.67 | 64.8 | 68.64 | 73.62 | |||||
EBIT / Interest Expense | 15.38 | 41.73 | 25.06 | 5.48 | 3.22 | |||||
EBITDA / Interest Expense | 26.52 | 54.29 | 33.53 | 10.91 | 7.66 | |||||
(EBITDA - Capex) / Interest Expense | 25.02 | 51.92 | 31.97 | 10.29 | 7.16 | |||||
Total Debt / EBITDA | 1.24 | 0.67 | 0.75 | 1.84 | 2.89 | |||||
Net Debt / EBITDA | -1.29 | -0.4 | 0.2 | 0.92 | 1.33 | |||||
Total Debt / (EBITDA - Capex) | 1.32 | 0.7 | 0.79 | 1.95 | 3.09 | |||||
Net Debt / (EBITDA - Capex) | -1.37 | -0.42 | 0.21 | 0.98 | 1.42 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -4.74 | 16.65 | 15.09 | -8.36 | -4.92 | |||||
Gross Profit, 1 Yr. Growth % | -15.59 | 44.17 | 1.28 | -31.44 | -16.91 | |||||
EBITDA, 1 Yr. Growth % | -22.36 | 99.57 | -6.01 | -60.21 | -48.95 | |||||
EBITA, 1 Yr. Growth % | -24.61 | 112.08 | -6.68 | -63.46 | -52.97 | |||||
EBIT, 1 Yr. Growth % | -29.42 | 126.87 | -6.95 | -66.26 | -56.22 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 29.47 | 150.73 | -10.31 | -103.54 | 59.18 | |||||
Net Income, 1 Yr. Growth % | 29.47 | 150.73 | -10.31 | -103.54 | 59.18 | |||||
Normalized Net Income, 1 Yr. Growth % | -30.19 | 136.66 | -7.87 | -69.91 | -64.63 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 17.42 | 150.27 | -6.48 | -103.64 | 58.23 | |||||
Accounts Receivable, 1 Yr. Growth % | -2.11 | 29.99 | 9.62 | 3.76 | -11.85 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -12.22 | -7.67 | 2.39 | -8.94 | 0.43 | |||||
Total Assets, 1 Yr. Growth % | -3.42 | 10.88 | -8.35 | -6.61 | -2.65 | |||||
Tangible Book Value, 1 Yr. Growth % | 5.31 | -12.8 | -23.87 | -19.05 | -29.11 | |||||
Common Equity, 1 Yr. Growth % | 2.16 | -8.67 | -15.81 | -16.81 | -16.3 | |||||
Cash From Operations, 1 Yr. Growth % | -98.31 | 2.76K | -3.49 | -42.18 | 14.72 | |||||
Capital Expenditures, 1 Yr. Growth % | -2.13 | 31.52 | 1.65 | -38.21 | -7.89 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -97.67 | 2.45K | -64.71 | 16.49 | 35.42 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -96.55 | 1.63K | -62.78 | 19.03 | 34.05 | |||||
Dividend Per Share, 1 Yr. Growth % | - | 133.61 | 5.26 | 0 | -58.67 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -3.54 | 5.41 | 15.87 | 2.7 | -6.66 | |||||
Gross Profit, 2 Yr. CAGR % | -19.54 | 10.31 | 20.84 | -16.67 | -20.73 | |||||
EBITDA, 2 Yr. CAGR % | -33.43 | 24.48 | 36.96 | -38.85 | -46.23 | |||||
EBITA, 2 Yr. CAGR % | -35.59 | 26.45 | 40.68 | -41.61 | -49.47 | |||||
EBIT, 2 Yr. CAGR % | -38.51 | 26.54 | 45.29 | -43.97 | -52.12 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -38.33 | 80.18 | 49.96 | -82.17 | -76.25 | |||||
Net Income, 2 Yr. CAGR % | -38.33 | 80.18 | 49.96 | -82.17 | -76.25 | |||||
Normalized Net Income, 2 Yr. CAGR % | -40.19 | 28.54 | 47.66 | -47.35 | -58.24 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -42.4 | 71.43 | 52.99 | -81.55 | -76.01 | |||||
Accounts Receivable, 2 Yr. CAGR % | -11.36 | 12.8 | 19.37 | 6.65 | -4.37 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 156.85 | -9.97 | -2.77 | -3.44 | -4.37 | |||||
Total Assets, 2 Yr. CAGR % | 11.65 | 3.48 | 0.81 | -7.48 | -3.61 | |||||
Tangible Book Value, 2 Yr. CAGR % | 19.94 | -4.18 | -18.52 | -21.49 | -24.25 | |||||
Common Equity, 2 Yr. CAGR % | 11.48 | -3.41 | -12.31 | -16.31 | -16.56 | |||||
Cash From Operations, 2 Yr. CAGR % | -81.15 | -30.38 | 425.52 | -25.3 | -18.56 | |||||
Capital Expenditures, 2 Yr. CAGR % | -17.45 | 13.46 | 15.63 | -20.75 | -24.56 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -75.57 | -22.81 | 200.22 | -35.88 | 42.57 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -70.26 | -22.72 | 153.72 | -33.44 | 41.98 | |||||
Dividend Per Share, 2 Yr. CAGR % | -44.56 | - | 56.81 | 2.6 | -35.71 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -0.61 | 2.77 | 8.55 | 7.15 | 0.09 | |||||
Gross Profit, 3 Yr. CAGR % | -12.42 | -2.27 | 7.22 | 0.03 | -13.98 | |||||
EBITDA, 3 Yr. CAGR % | -23.09 | -4.01 | 13.35 | -9.29 | -35.22 | |||||
EBITA, 3 Yr. CAGR % | -24.82 | -4.17 | 14.27 | -10.24 | -38.01 | |||||
EBIT, 3 Yr. CAGR % | -26.99 | -4.99 | 14.21 | -10.7 | -40.25 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -28.15 | -1.57 | 42.79 | -56.97 | -63.02 | |||||
Net Income, 3 Yr. CAGR % | -28.15 | -1.57 | 42.79 | -56.97 | -63.02 | |||||
Normalized Net Income, 3 Yr. CAGR % | -28.25 | -5.4 | 15.03 | -13.11 | -45.64 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -31.45 | -6.01 | 40.07 | -56 | -62.24 | |||||
Accounts Receivable, 3 Yr. CAGR % | -6.95 | 0.71 | 11.73 | 13.92 | 0.09 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 95.13 | 82.63 | -6.03 | -4.87 | -2.17 | |||||
Total Assets, 3 Yr. CAGR % | 7.49 | 11.39 | -0.62 | -1.73 | -5.21 | |||||
Tangible Book Value, 3 Yr. CAGR % | 11.41 | 7.85 | -11.25 | -18.7 | -24.12 | |||||
Common Equity, 3 Yr. CAGR % | 7.56 | 4.31 | -7.73 | -13.84 | -16.31 | |||||
Cash From Operations, 3 Yr. CAGR % | -66.7 | 0.55 | -22.37 | 151.81 | -13.82 | |||||
Capital Expenditures, 3 Yr. CAGR % | -15.22 | -3.58 | 9.38 | -6.17 | -16.68 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -59.71 | 15.07 | -40.53 | 118.97 | -10.48 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -54.12 | 15.23 | -39.42 | 97.15 | -9.13 | |||||
Dividend Per Share, 3 Yr. CAGR % | -31.59 | -10.46 | - | 34.98 | -24.23 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 5.95 | 5.34 | 5.68 | 2.74 | 2.19 | |||||
Gross Profit, 5 Yr. CAGR % | -2.39 | 1.63 | -0.39 | -8.31 | -4.98 | |||||
EBITDA, 5 Yr. CAGR % | -10.1 | 0.22 | -3.12 | -19.85 | -15.88 | |||||
EBITA, 5 Yr. CAGR % | -11.26 | 0.14 | -3.4 | -21.4 | -17.55 | |||||
EBIT, 5 Yr. CAGR % | -11.91 | 0.4 | -3.85 | -23.08 | -19.33 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -12.67 | 2.08 | -3.56 | -50.31 | -30.32 | |||||
Net Income, 5 Yr. CAGR % | -13.16 | 2.08 | -3.56 | -50.31 | -30.32 | |||||
Normalized Net Income, 5 Yr. CAGR % | -12.63 | 0.38 | -4.23 | -25.17 | -23.3 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -15.34 | -0.92 | -5.49 | -51 | -30.84 | |||||
Accounts Receivable, 5 Yr. CAGR % | 0.94 | 2.5 | 2.8 | 3.04 | 4.99 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 61.52 | 52.97 | 47.68 | 41.53 | -5.37 | |||||
Total Assets, 5 Yr. CAGR % | 10.86 | 9.67 | 4.76 | 3.42 | -1.83 | |||||
Tangible Book Value, 5 Yr. CAGR % | 23.78 | 9.68 | -1.7 | -5.02 | -16.7 | |||||
Common Equity, 5 Yr. CAGR % | 13.75 | 6.31 | -0.88 | -4.49 | -11.37 | |||||
Cash From Operations, 5 Yr. CAGR % | -43.39 | 5.08 | 0.39 | -10.72 | -20.87 | |||||
Capital Expenditures, 5 Yr. CAGR % | -2.23 | -1.27 | -4.02 | -10.86 | -5.73 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -33.59 | 11.03 | -10.03 | -8.93 | -15.63 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -28.61 | 10.85 | -9.07 | -7.48 | -14.83 | |||||
Dividend Per Share, 5 Yr. CAGR % | -15.9 | -2.41 | -4.67 | -5.45 | - |
- Stock Market
- Stocks
- HAS Stock
- Financials Hays plc
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















